Clinical Trial Update: The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of rosuvastatin plus ezetimibe versus rosuvastatin alone in hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Zetia (ezetimibe)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Hypercholesterolemia | Phase 3 | Status: UNKNOWN